Solution to morphine's side-effect in sight

Editors' Picks

  • Guardiola raises doubts over Schweinsteiger's fitness

    Guardiola raises doubts over Schweinsteiger's fitness

    Guardiola raises doubts over Schweinsteiger's fitness

    (Reuters) - Bayern Munich manager Pep Guardiola has cast a doubt on Manchester United's new midfielder Bastian Schweinsteiger by saying his former player was never fully fit during the last three seasons. Guardiola said the 31-year-old Schweinsteiger can only be a success at the Premier League club if he can shake off his injury problems. "When he does not have injury problems, I am completely convinced he will do very well at Manchester United," Guardiola was quoted as saying by the British …

  • Ki hopes to upset Chelsea in Swansea's League opener

    Ki hopes to upset Chelsea in Swansea's League opener

    Ki hopes to upset Chelsea in Swansea's League opener

    (Reuters) - Swansea City midfielder Ki Sung-yueng hopes his side can repeat last season's opening-day shock when they face champions Chelsea at Stamford Bridge in the Premier League this weekend. Ki scored in the win over Manchester United on the first day of last season as Swansea went on the finish a creditable eighth in the Premier League. "We had the perfect start last year which set us up for the rest of the campaign," the 26-year-old South Korean international was quoted as saying on …

  • Ferdinand advises Stones to choose United over Chelsea

    Ferdinand advises Stones to choose United over Chelsea

    Ferdinand advises Stones to choose United over Chelsea

    Former England international Rio Ferdinand feels Everton's John Stones should pick Manchester United over Chelsea if the defender prefers more playing time. Champions Chelsea have had bids for the 21-year-old defender turned down with other clubs, including United, also in the fray, according to British media reports. "If he goes to Man United, he plays every week so that's the right club for him," former England captain and centreback Ferdinand said. …

  • Rafael joins Lyon from United on four-year deal

    Rafael joins Lyon from United on four-year deal

    Rafael joins Lyon from United on four-year deal

    Brazil defender Rafael will join Olympique Lyonnais on a four-year deal from Manchester United after both clubs reached an agreement, the Ligue 1 side said on Monday. "Olympique Lyonnais inform that they have found an agreement with Manchester United over the transfer of Brazilian international defender Rafael da Silva who will sign a four-year deal in the coming days," the club said on their official website. Rafael, who won two caps for Brazil, made 109 Premier League appearances and won …

  • UEFA club coefficient rankings: Real Madrid on top, Manchester United way behind in 20th position

    UEFA club coefficient rankings: Real Madrid on top, Manchester United way behind in 20th position

    UEFA club coefficient rankings: Real Madrid on top, Manchester United way behind in 20th position

    Real Madrid continue leading the UEFA club coefficient rankings while Barcelona fall down a place to 3rd. Manchester United languish back in 20th position. …

  • Di Maria on verge of PSG medical, reports British media

    Di Maria on verge of PSG medical, reports British media

    Di Maria on verge of PSG medical, reports British media

    Manchester United's Argentine winger Angel Di Maria is set to have a medical ahead of a proposed transfer to French champions Paris St-Germain a year after arriving at Old Trafford for a British record transfer fee, local media reported on Sunday. Di Maria joined United from Real Madrid for a fee of 59.7 million pounds ($92.59 million) but, after an impressive start to his Reds career, struggled to display the form that made him one of the most feared attackers in Europe. Di Maria scored or …

Toronto, Jan 7 (IANS) Popular painkiller drug morphine comes with a devastating side-effect, inflicting greater pain on users rather than easing their agony. But this could hopefully be a thing of the past, says a study that found new ways to make the drug more effective.

"Our research identifies a molecular pathway by which morphine can increase pain, and suggests potential new ways to make morphine effective for more patients," says senior author Yves De Koninck, professor at Universite Laval in Quebec City, Canada.

The team included researchers from the Hospital for Sick Children (SickKids) in Toronto, the Institut Universitaire en Sante Mentale de Quebec, the US and Italy, the journal Nature Neuroscience reports.

Pain has been labelled the silent health crisis, afflicting tens of millions of people worldwide. Pain has a profound negative effect on the quality of human life, according to a Laval statement.

"When morphine doesn't reduce pain adequately, the tendency is to increase the dosage. If a higher dosage produces pain relief, this is the classic picture of morphine tolerance, which is very well known," explains study co-author Michael Salter.

"But sometimes increasing the morphine can, paradoxically, make the pain worse," adds Salter, senior scientist and head of neurosciences and mental health, at SickKids and professor of physiology at University of Toronto.

"Pain experts have thought tolerance and hypersensitivity (or hyperalgesia, sensitivity to pain) are simply different reflections of the same response," says De Koninck, "but we discovered that cellular and signalling processes for morphine tolerance are very different from those of morphine-induced pain."

Researchers also identified the molecule behind morphine side-effect as "a protein called KCC2, which regulates the transport of chloride ions and the proper control of sensory signals to the brain," says De Koninck.

"Morphine inhibits the activity of this protein, causing abnormal pain perception. By restoring normal KCC2 activity we could potentially prevent pain hypersensitivity."

De Koninck and researchers at Universite Laval are testing new molecules capable of preserving KCC2 functions and thus preventing hyperalgesia.